588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Anti-Cd33 Car-Nk Cells Acute Myeloid Leukemia	Nationwide Children's Hospital	P1/2	CC (45)
Anti-Cll1 Cart Cells Acute Myeloid Leukemia	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China	P1/2	CC (45)
bg1805 Acute Myeloid Leukemia	Guangzhou Bio-gene Technology Co., Ltd	P1/2	CC (45)
BN104 Acute Myeloid Leukemia	Chen Suning	P1/2	CC (45)
Car.70/Il15-Transduced Cb-Nk Cells Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1/2	CC (45)
cd123-car-nk cells Acute Myeloid Leukemia	Chongqing Precision Biotech Co., Ltd	P1/2	CC (45)
CD123-CAR T Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	CC (45)
cd123-cd33 ccar t cells Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (45)
cd33cart allogeneic Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P1/2	CC (45)
cd33cart autologous Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P1/2	CC (45)
cd7-specific car gene-engineered t cells Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	CC (45)
Dual-Target Antigen-Selected Car-Nk Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (45)
Dubermatinib Acute Myeloid Leukemia	Uma Borate	P1/2	CC (45)
E-7820 Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P2	CC (45)
Eb-Select Single-Target Car-Nk Cells Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (45)
Enzomenib Acute Myeloid Leukemia	Sumitomo Pharma America, Inc.	P1/2	CC (45)
Mb-Dnpm1-Tcr.1 Acute Myeloid Leukemia	Miltenyi Biomedicine GmbH	P1/2	CC (45)
Orca-Q Acute Myeloid Leukemia	University of Florida	P1/2	CC (45)
rc1012 Acute Myeloid Leukemia	Guangdong Ruishun Biotech Co., Ltd	P1/2	CC (45)
Sndx-5613 Acute Myeloid Leukemia	Syndax Pharmaceuticals	P1/2	CC (45)
Supcd7 Cart Cells Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1/2	CC (45)
Tuspetinib Acute Myeloid Leukemia	Aptose Biosciences Inc.	P1/2	CC (45)
Vcar33 Acute Myeloid Leukemia	Vor Biopharma	P1/2	CC (45)
vor33 Acute Myeloid Leukemia	Vor Biopharma	P1/2	CC (45)
Zn-D5 Zn-C3 Acute Myeloid Leukemia	K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.	P1/2	CC (45)
Γδ T Cells Acute Myeloid Leukemia	Chinese PLA General Hospital	P1/2	CC (45)
prt2527 Acute Myeloid Leukemia	Prelude Therapeutics	P1	CC (44)
Zanubrutinib Acute Myeloid Leukemia	Prelude Therapeutics	P1	CC (44)
Allogeneic Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T-Lymphocytes Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (43)
Amg 553 Acute Myeloid Leukemia	Amgen	P1	CC (43)
Anti-Cd123 Car Nk Cells Acute Myeloid Leukemia	Chongqing Precision Biotech Co., Ltd	P1	CC (43)
Anti-Cd33 Cart Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (43)
Anti-Cll-1 Car Nk Cells Acute Myeloid Leukemia	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	P1	CC (43)
Anti-Flt3 Car-T Cells Acute Myeloid Leukemia	Hemogenyx Pharmaceuticals LLC	P1	CC (43)
Anti-Lilra6 Car-T Cells Acute Myeloid Leukemia	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1	CC (43)
Apl-4098 Acute Myeloid Leukemia	Apollo Therapeutics Ltd	P1	CC (43)
Autologous Anti-Cd83 Car T-Cells Acute Myeloid Leukemia	Roswell Park Cancer Institute	P1	CC (43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (43)
Autologous Fl-33 Car T Therapy Acute Myeloid Leukemia	Beijing GoBroad Hospital	P1	CC (43)
Autx-703 Acute Myeloid Leukemia	Auron Therapeutics, Inc.	P1	CC (43)
Azenosertib Acute Myeloid Leukemia	K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.	P1/2	CC (43)
b7-h3 target, car gene modified gdt cell Acute Myeloid Leukemia	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	P1	CC (43)
Bosutinib Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (43)
BP1002 Acute Myeloid Leukemia	Bio-Path Holdings, Inc.	P1	CC (43)
bp1002; liposomal bcl-2 antisense oligodeoxynucleotide Acute Myeloid Leukemia	Bio-Path Holdings, Inc.	P1	CC (43)
Bsb-2002 Acute Myeloid Leukemia	BlueSphere Bio, Inc	P1	CC (43)
Cart123 Cells Acute Myeloid Leukemia	University of Pennsylvania	P1	CC (43)
cb-012 Acute Myeloid Leukemia	Caribou Biosciences, Inc.	P1	CC (43)
Cbx-250 Acute Myeloid Leukemia	Crossbow Therapeutics, Inc.	P1	CC (43)

Showing 251 to 300 of 588 assets

PreviousPage 6 of 12Next